Supplementary Table 1 from Phase I trial of the multi-kinase inhibitor cabozantinib, a CYP3A4 substrate, plus CYP3A4 interacting antiretroviral therapy in people living HIV and cancer (AMC087)
Authors:
- Missak HaigentzMHMissak Haigentz
- Jeannette Y. LeeJLJeannette Y. Lee
- Elizabeth Y. ChiaoECElizabeth Y. Chiao
- David M. AboulafiaDADavid M. Aboulafia
- Lee RatnerLRLee Ratner
- Richard F. AmbinderRARichard F. Ambinder
- Robert A. BaiocchiRBRobert A. Baiocchi
- Ronald T. MitsuyasuRMRonald T. Mitsuyasu
- William WachsmanWWWilliam Wachsman
- Joseph A. SparanoJSJoseph A. Sparano
- Michelle A. RudekMRMichelle A. Rudek
Open Access
- 16 September 2024
- other
- Published by American Association for Cancer Research (AACR)